Revelation Biosciences, Inc. (REVB)
USD 0.34
(1.75%)
USD 0.34
(1.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 25.04 Thousand | 40 Thousand | 69.16 Thousand | - | - |
| Gross Profit | -25.04 Thousand | -40 Thousand | -69.16 Thousand | - | - |
| Operating Expenses | 8.65 Million | 10.86 Million | 11.95 Million | 145.49 Thousand | 3638.00 |
| Selling, General and Administrative Expenses | 4.51 Million | 5.48 Million | 5.03 Million | 145.49 Thousand | 3638.00 |
| Research and Development Expenses | 4.14 Million | 5.37 Million | 6.91 Million | 2.56 Million | - |
| Other Expenses | - | 34.96 Thousand | -36.35 Thousand | - | - |
| Cost and Expenses | 8.65 Million | 10.86 Million | 11.95 Million | 145.49 Thousand | 3638.00 |
| Operating Income | -8.65 Million | -10.86 Million | -11.95 Million | -145.49 Thousand | -3640.00 |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -34.96 Thousand | -219.77 Thousand | -3795.82 | -171.86 Thousand |
| Earnings before Tax | -120.25 Thousand | -10.82 Million | -11.98 Million | -1.63 Million | -3638.00 |
| Net Income | -120.25 Thousand | -10.79 Million | -11.98 Million | -1.63 Million | -3638.00 |
| Earnings Per Share Basic | -0.53 | -600.77 | -1275.02 | -188.18 | -0.42 |
| Earnings Per Share Diluted | -0.53 | -600.77 | -1275.02 | -188.18 | -0.42 |
| Weighted Average Shares Outstanding | 228 Thousand | 17.96 Thousand | 9401.31 | 8664.47 | 8664.47 |
| Weighted Average Shares Outstanding (Diluted) | 228.64 Thousand | 17.96 Thousand | 9401.31 | 8664.47 | 8664.47 |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -95.2 Thousand | -10.83 Million | -11.93 Million | -145.49 Thousand | -3640.00 |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 37.57 Thousand | - | - | - |
| Cost of Revenue | 7220.00 | 6262.00 | 6262.00 | 25.04 Thousand | 6262.00 | 6262.00 |
| Gross Profit | -7220.00 | -6262.00 | 31.31 Thousand | -25.04 Thousand | -6262.00 | -6262.00 |
| Operating Expenses | 2.51 Million | 1.89 Million | 2.31 Million | 8.63 Million | 2.77 Million | 1.93 Million |
| Selling, General and Administrative Expenses | 1.12 Million | 1.17 Million | 1.25 Million | - | 1.12 Million | 1.02 Million |
| Research and Development Expenses | 1.39 Million | 717.58 Thousand | 1.05 Million | - | 1.65 Million | 909.27 Thousand |
| Other Expenses | -5.87 Million | -847.72 Thousand | 54.78 Thousand | - | 56.96 Thousand | 61.62 Thousand |
| Cost and Expenses | 2.52 Million | 1.9 Million | 2.32 Million | 8.65 Million | 2.77 Million | 1.93 Million |
| Operating Income | -2.52 Million | -1.9 Million | -2.32 Million | -8.65 Million | -2.77 Million | -1.93 Million |
| Interest Expense | - | - | 7.77 Million | - | - | - |
| Income Tax Expense | - | -2.00 | -2.00 | 1.00 | -92.56 Thousand | -423.23 Thousand |
| Earnings before Tax | -8.38 Million | -2.68 Million | -2.2 Million | -120.25 Thousand | -2.62 Million | -1.44 Million |
| Net Income | -8.38 Million | -2.68 Million | -2.2 Million | -120.25 Thousand | -2.62 Million | -1.44 Million |
| Earnings Per Share Basic | -5.13 | -2.46 | -8.34 | - | -12.52 | -5.83 |
| Earnings Per Share Diluted | -5.13 | -2.46 | -8.33 | - | -12.52 | -5.83 |
| Weighted Average Shares Outstanding | 1.63 Million | 1.08 Million | 264 Thousand | 228 Thousand | 209.91 Thousand | 248.36 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.63 Million | 1.08 Million | 264.53 Thousand | 228.64 Thousand | 209.91 Thousand | 248.36 Thousand |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -61.73 | - | - | - |
| Profit Margin | - | - | -58.63 | - | - | - |
| EBITDA | -2.51 Million | -1.89 Million | -2.31 Million | - | -2.86 Million | -2.35 Million |
| Earnings Before Tax Margin | - | - | -61.90 | - | - | - |
KOCMT
LOVABLE
UNITECH
CERGF
PAR
1522